Objectives: to prospectively evaluate the mid-term results of endovascular and open repair in patients with
Introduction
endovascular repair are generally good, with a mortality rate varying from 0% to 4.5%. [4] [5] [6] [7] [8] However, since Endovascular repair of abdominal aortic aneurysm the technology is recent and rapidly evolving, only a (AAA) is currently proposed as an alternative to open few reports are available to assess the mid-term results surgery 1 because it is less invasive for patients who of endovascular repair as compared to those of open have severe co-morbidity and a risk of early death surgery. The main uncertainty remains the long-term from open surgery close to 5.5%.
2, 3 Early results of efficacy of the EV repair, 9 which may be threatened by endoleaks, graft distortion, limb graft occlusion, and material fatigue. Thus, with the current lack of with AAA anatomically suitable for endovascular studied in the EV group. Endoleaks were defined according to the modified classification of White.
10,11
repair. Type I and type III endoleaks were treated aggressively; type II endoleaks were managed more conservatively. In the latter case, intervention was only Materials and Methods done when the aneurysm diameter increased by 20% on surveillance CT scans. Between January 1995 and March 1999, 438 patients
The main endpoints were death and reintervention. referred to our institution for elective AAA repair The latter included, for both groups, various open or were routinely assessed by CT scan and angiogram. endovascular procedures performed to treat comOne hundred and eighty (41%) were considered to be plications, to improve or to restore patency of the graft anatomically suitable for endovascular repair since or limb and/or graft replacement; and, in the EV they fulfilled the following criteria: upper neck group, attempt to close endoleaks. [1.5 cm in length and less than 30 mm in diameter,
The statistical analysis included the Chi-squared preservation of at least one patent non-aneurysmal test, Student's t-test, life-table analysis and log-rank internal iliac artery, no major angulation of the aorta test. and/or the iliac arteries, and iliac arteries without extensive occlusive disease or calcification. The choice between open and endovascular repair varied over the period of the study. The first endovascular cases Results were high-risk patients. However, with increasing expertise and confidence, in the last 2 years of the They were 107 OR and 73 EV. Median age, sex ratio, and preoperative risk factors are listed in Table 1 . series, when the anatomical criteria were met, the endovascular technique was proposed as a first option The distribution of risk factors was not statistically different. However, when we investigated the asas soon as the hospital resources allowed the purchase of the devices, and the patients accepted the un-sociation of the following risk factors (diabetes mellitus, severe obesity, unstable angina, left-ventricular certainty of the EV repair and signed an informed consent. Only commercially available grafts were im-ejection fraction <30%, renal insufficiency defined by a creatinine level >200 mol/l or dialysis, and severe planted. Bifurcated grafts were chosen whenever possible. Aorto-uni-iliac grafts, with occlusion of the respiratory insufficiency defined by VEMS <1.2 l and/ or pCO 2 >45 mmHg), the percentage of patients with contralateral common iliac artery by a manufactured occluder and femorofemoral bypass, were used when two or more risk factors was 8.3% in the OR and 22% in the EV group (p=0.01). Average aneurysm diameter one of the iliac arteries was unsuitable (too large, angulated or diseased).
was 50.5 mm±11 mm in the OR and 50 mm±5.5 mm in the EV group (NS). Postoperatively, patients were followed on an outpatient basis. Patients with open repair had a visit at
In the EV group, various endovascular grafts were implanted. Preoperative risk factors were graded according to bifurcated grafts, three tube grafts, and three aortouni-iliac and femorofemoral grafts. Intraoperative data the SVS/ISCVS classification. They were recorded prospectively in a computerised database (J. Meunier, are shown in Table 2 . Postoperatively, the duration of hospitalisation was 13 days±7 for OR and 7 days±2 Logit), as well as imaging parameters, intraoperative data, and postoperative events.
for EV (p<0.01). The 1-month mortality was 2 (2.7%) for EV and 2 Between January 1999 and August 1999, the database was checked and missing data entered whenever pos-(2.8%) for OR. In the OR group, the causes of death were two myocardial infarcts and one complicated sible. Patients who had not complied with the surveillance protocol were contacted by phone and pneumonia. In the EV group, the two deaths may have been graft-related. One of these patients, who had submitted to the expected visit and examination.
Endoleaks and aneurysm diameters were also been denied open repair due to severe co-morbidities, was treated uneventfully with a Stentor graft. Two Major complications were observed in 28 (26.2%) of the OR group and 11 (15%) of the EV group (NS) hours later, while in the recovery room, he presented with septic-like shock and the graft occluded. Despite (Table 3 ). The rate of cardiac and pulmonary complications was significantly higher in the OR group emergent thrombectomy and resuscitation measures, he subsequently died of cardiac insufficiency. The (p=0.017). The local, non-vascular complications rate was 2 (1.9%) and 1 (1.4%), respectively. second patient, a 79-year-old high-risk patient, was treated with an EVT device. While deploying the The median follow-up was 7 months in the EV group (range 4 days to 40 months), and 19 months in second limb of the graft, the left common iliac artery was lacerated by the distal metallic hooks. In an at-the OR group (range 4 days to 51 months). During follow-up, in the EV group, there were three deaths tempt to control the bleeding by a retroperitoneal approach, the vena cava was injured and finally re-from cardiac disease and two from liver and pulmonary malignancies. In the OR group there were two paired. The left iliac artery was ligated and a femorofemoral bypass performed. The patient died 5 weeks deaths from cardiac diseases and one from pulmonary cancer. Cumulative survival is shown in Figure 1 . later of multiple organ failure. group were converted to open surgery, or because their aneurysm grew to 65 mm, with no sign of endoleak; one because the graft occluded three times, and one because of a distal endoleak which could not be treated by a new endovascular graft. All these three patients remain well.
In total, 16 patients (22%) in the EV and eight (7.5%) in the OR required a subsequent vascular reintervention (p=0.001) ( Table 4) . Primary success, defined by the absence of endoleak and/or the absence of reintervention, was 54 (74%) with EV and 101 (94%) with OR (p=0.001). 
Discussion
Only a few studies have compared OR and EV for the treatment of AAA. Early results have been reported by the Sydney group 12 which has compared two groups of 27 and 28 patients fit and suitable for both OR and EV. A similar study by Brewster 13 included 30 patients whose data and outcomes were compared to a matched control group of OR. Early and 6-month results were also reported by Zarins 14 with a multicentre prospective study of 190 AneuRX grafts, which was compared to 60 patients who underwent OR and who met the criteria for entering the EV group. Finally, the was historical and the two groups were not strictly identical. Forty-four percent of patients in the EV group were poor candidates for open surgery, and On the first post-operative CT scan there were 17 endoleaks (23.3%) in the EV group: eight type I and patients in the OR group had AAA morphological features unsuitable for EV. nine type II. On the last available CT scan, there were five type I and two type II endoleaks.
The present prospective study compared 180 consecutive patients and was carried out in a single inIn the EV group, 12 grafts occluded or developed a stenosis (16.4%). Two patients had external iliac artery stitution. Patients in both groups were anatomically suitable for endovascular repair. Patients with complex stenoses prior to implantation; these were treated by angioplasty at the time of graft insertion. Two more aneurysms, involving the renal artery and/or extending down both internal iliac arteries were expatients developed external iliac artery stenosis following implantation. Finally, eight patients developed cluded. Of note is that this later group is at higher risk for early mortality with OR. 16 The current study stenosis or thrombosis within the graft itself. In three EVT grafts, it was thought that the limbs of the graft has, nevertheless, some obvious flaws. The distribution of procedures varied with time. A great number of had twisted. In five modular grafts, the stenosis and occlusions occurred on the contralateral limb. None patients in the EV group were treated during the most recent part of this study and have a shorter followof these cases were thought due to graft kinking secondary to AAA remodelling. Thrombolysis and up. The EV group included our very first cases and suffers the consequence of the learning curve effect. correction of residual stenosis or twist restored graft patency by angioplasty and stenting. In three patients Finally, despite the fact that the distribution of individual risk factors was not statistically significant in this option was not feasible or failed and as a limb remained patent, a crossover femorofemoral bypass the two groups, more patients in the EV group had multiple associated severe-risk factors. was performed.
No AAA ruptured, but three patients in the EV Our study confirms the advantages of EV during the early postoperative period. Operative mortality differences, although not statistically significant, in the survival rate between open and endovascular repair was similar (2.8% and 2.7%), confirming previous studies of May 14 and Brewster 13 who found respectively with 2-year survival rates of 92% and 88% respectively. Thus, we agree with the conclusions of May, who 5.6% and 0% in both groups. The two early deaths in the EV group observed in our early practice were stated that endovascular repair is a safe procedure and that further evaluations may go on. related to graft complications and occurred in highrisk patients. It may be assumed that, with a greater One key finding of our study is the high incidence of secondary procedures among the EV group which expertise and improvement of the devices, these serious complications may be avoidable in the future.
were necessitated during the follow-up to treat endoleak, or improve or restore patency of the graft. The lower requirement for transfusion was notable in the EV group, as it was in the study of White 12 This finding has already been observed in the French Vanguard study. 17 None of our patients had a ruptured (mean 873 ml vs. 1422 ml), Brewster 13 (mean 498 ml vs. 1287 ml), and Zarins 14 (mean 641 ml vs. 1596 ml). We AAA during the follow-up, but three patients had to be converted to open surgical repair for obvious failure. found that the total duration of hospitalisation was reduced by 6 days in the EV group, in agreement with Endoleaks were treated electively according to their aetiology. Type I endoleak required proximal cuff or the findings of Brewster 13 (3.9 days versus 10.3 days) and Zarins 14 (3.4 days versus 9.4 days). White 12 and distal extension and persistent type II endoleak, lumbar, internal iliac or inferior mesenteric emBrewster 13 also reported a shorter stay in the intensive care unit for the EV group. EV was also associated bolisation. Not all these attempts were easy, or successful. Unexpected acute occlusion of graft limbs was with fewer general complications as underlined by previous authors 13 (4% versus 18%), 14 (3% versus 12%). more dramatic, with the need for urgent hospitalisation and treatment by thrombolysis and stenting or open In our series, the most dramatic improvement was the rate of pulmonary complications, which was reduced surgery. Even if the secondary procedures were mostly endovascular and did not affect mortality, they are an by 60% with the EV technique.
Vascular complications were infrequent in the cur-obvious drawback for this method as compared to open repair. The future of EV graft technology for rent series, which can be explained by the use of commercially available grafts with adequate in-AAA will depend upon the way the late failures will be prevented. Failure may be divided into three troducers and the selection of patients who had healthy external iliac arteries.
categories: inadequate sealing during implantation, graft-related failure, and failure due to AAA evolution. Long-term results of endovascular grafting remain to be evaluated. We found a slightly higher mortality During implantation, recognition and immediate treatment of type I endoleak is an obvious way of improving rate in the EV group, which may be explained by a slightly higher risk group when the association of the results. They require an excellent preoperative assessment of the aneurysm features, a good technical multiple risk factors was analysed. 
